Advances in Treatment of Locally Advanced Renal Cell Carcinoma
10.3971/j.issn.1000-8578.2023.22.1542
- VernacularTitle:局部进展期肾癌综合治疗研究进展
- Author:
Jiaqi SU
1
,
2
;
Hailiang ZHANG
Author Information
1. Department of Urology, Fudan University Shanghai Cancer Center
2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
- Publication Type:Research Article
- Keywords:
Locally advanced renal cell carcinoma;
Neoadjuvant therapy;
Surgical treatment;
Adjuvant therapy;
Clinical trial
- From:
Cancer Research on Prevention and Treatment
2023;50(6):556-561
- CountryChina
- Language:Chinese
-
Abstract:
Renal cell carcinoma (RCC) is the third most common malignant tumor of the genitourinary system. During disease progression, RCC can undergo local and/or distant metastasis, which seriously affects the prognosis of the patient. With the advancements in targeted therapy and immunotherapy for advanced RCC, treatment for locally advanced RCC has changed. Studies have focused on applying targeted therapy or immunotherapy in the perioperative period. This article aims to review progress on treatment of locally advanced RCC to offer references for novel treatment strategies.
